Gail A. Van Norman

3.3k total citations · 1 hit paper
55 papers, 2.0k citations indexed

About

Gail A. Van Norman is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Surgery. According to data from OpenAlex, Gail A. Van Norman has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 13 papers in Economics and Econometrics and 11 papers in Surgery. Recurrent topics in Gail A. Van Norman's work include Pharmaceutical Economics and Policy (12 papers), Cardiac, Anesthesia and Surgical Outcomes (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Gail A. Van Norman is often cited by papers focused on Pharmaceutical Economics and Policy (12 papers), Cardiac, Anesthesia and Surgical Outcomes (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Gail A. Van Norman collaborates with scholars based in United States, Canada and France. Gail A. Van Norman's co-authors include Victor Chan, Karen L. Posner, Stephen Jackson, Diane Doerner, Dominic Reilly, M. Mora, Stephan D. Fihn, Timothy R.B. Johnson, Marguerite J. McNeely and J Coffey and has published in prestigious journals such as PLoS ONE, CHEST Journal and Anesthesiology.

In The Last Decade

Gail A. Van Norman

49 papers receiving 2.0k citations

Hit Papers

Limitations of Animal Studies for Predicting Toxicity in ... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gail A. Van Norman United States 20 488 439 391 321 267 55 2.0k
Li Zhu China 16 390 0.8× 332 0.8× 199 0.5× 804 2.5× 687 2.6× 54 7.0k
Peng Xia China 23 405 0.8× 297 0.7× 176 0.5× 1.2k 3.7× 689 2.6× 103 7.6k
Valentina Lorenzoni Italy 26 651 1.3× 728 1.7× 245 0.6× 612 1.9× 381 1.4× 120 3.7k
Qian Zhou China 32 635 1.3× 624 1.4× 156 0.4× 874 2.7× 490 1.8× 246 4.4k
Mir S. Siadaty United States 21 321 0.7× 330 0.8× 119 0.3× 339 1.1× 172 0.6× 34 2.3k
Mohamed B. Elshazly United States 24 1.3k 2.7× 1.1k 2.6× 215 0.5× 264 0.8× 127 0.5× 64 2.9k
Ling Li China 27 862 1.8× 290 0.7× 169 0.4× 425 1.3× 198 0.7× 118 3.2k
Camilla Mattiuzzi Italy 34 391 0.8× 298 0.7× 243 0.6× 974 3.0× 525 2.0× 170 4.4k
Steven E. Kern United States 33 702 1.4× 214 0.5× 125 0.3× 716 2.2× 244 0.9× 103 3.4k

Countries citing papers authored by Gail A. Van Norman

Since Specialization
Citations

This map shows the geographic impact of Gail A. Van Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail A. Van Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail A. Van Norman more than expected).

Fields of papers citing papers by Gail A. Van Norman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail A. Van Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail A. Van Norman. The network helps show where Gail A. Van Norman may publish in the future.

Co-authorship network of co-authors of Gail A. Van Norman

This figure shows the co-authorship network connecting the top 25 collaborators of Gail A. Van Norman. A scholar is included among the top collaborators of Gail A. Van Norman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail A. Van Norman. Gail A. Van Norman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Norman, Gail A. Van. (2023). Off-Label Use vs Off-Label Marketing of Drugs. JACC Basic to Translational Science. 8(2). 224–233. 18 indexed citations
2.
Norman, Gail A. Van. (2023). Off-Label Use vs Off-Label Marketing. JACC Basic to Translational Science. 8(3). 359–370. 3 indexed citations
3.
Norman, Gail A. Van. (2021). Data Safety and Monitoring Boards Should Be Required for Both Early- and Late-Phase Clinical Trials. JACC Basic to Translational Science. 6(11). 887–896. 4 indexed citations
4.
Norman, Gail A. Van. (2020). Update to Drugs, Devices, and the FDA. JACC Basic to Translational Science. 5(8). 831–839. 11 indexed citations
5.
Norman, Gail A. Van. (2019). Phase II Trials in Drug Development and Adaptive Trial Design. JACC Basic to Translational Science. 4(3). 428–437. 75 indexed citations
6.
Shah, Aalap, et al.. (2018). Self-reported functional status predicts post-operative outcomes in non-cardiac surgery patients with pulmonary hypertension. PLoS ONE. 13(8). e0201914–e0201914. 10 indexed citations
7.
Norman, Gail A. Van, et al.. (2017). Technology Transfer: From the Research Bench to Commercialization. JACC Basic to Translational Science. 2(2). 197–208. 30 indexed citations
8.
Norman, Gail A. Van, et al.. (2017). Technology Transfer: From the Research Bench to Commercialization. JACC Basic to Translational Science. 2(1). 85–97. 40 indexed citations
9.
Norman, Gail A. Van. (2017). Overcoming the Declining Trends in Innovation and Investment in Cardiovascular Therapeutics. JACC Basic to Translational Science. 2(5). 613–625. 22 indexed citations
10.
Norman, Gail A. Van. (2016). Decisions regarding forgoing life-sustaining treatments. Current Opinion in Anaesthesiology. 30(2). 211–216. 6 indexed citations
11.
Norman, Gail A. Van. (2016). Drugs, Devices, and the FDA: Part 1. JACC Basic to Translational Science. 1(3). 170–179. 232 indexed citations
12.
Norman, Gail A. Van. (2016). Drugs, Devices, and the FDA: Part 2. JACC Basic to Translational Science. 1(4). 277–287. 136 indexed citations
13.
Norman, Gail A. Van. (2014). Physician aid-in-dying. Current Opinion in Anaesthesiology. 27(2). 177–182. 5 indexed citations
14.
Norman, Gail A. Van. (2003). Ethical issues and the role of anesthesiologists in non-heart-beating organ donation. Current Opinion in Anaesthesiology. 16(2). 215–219. 5 indexed citations
15.
Norman, Gail A. Van & Susan K. Palmer. (2001). The Ethical Boundaries of Persuasion: Coercion and Restraint of Patients in Clinical Anesthesia Practice. International Anesthesiology Clinics. 39(3). 131–143. 6 indexed citations
16.
Norman, Gail A. Van, et al.. (2000). Effects of hemofiltration on serum aprotinin levels in patients undergoing cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia. 14(3). 253–256. 9 indexed citations
17.
Posner, Karen L., Gail A. Van Norman, & Victor Chan. (1999). Adverse Cardiac Outcomes After Noncardiac Surgery in Patients with Prior Percutaneous Transluminal Coronary Angioplasty. Anesthesia & Analgesia. 89(3). 553–553. 55 indexed citations
18.
Reilly, Dominic, Marguerite J. McNeely, Diane Doerner, et al.. (1999). Self-reported Exercise Tolerance and the Risk of Serious Perioperative Complications. Archives of Internal Medicine. 159(18). 2185–2185. 234 indexed citations
19.
Sebban, Catherine, George P. Browman, Amiram Gafni, et al.. (1995). Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia. American Journal of Hematology. 48(4). 221–227. 47 indexed citations
20.
Norman, Gail A. Van, Edward G. Pavlin, A. Craig Eddy, & D. Janet Pavlin. (1991). Hemodynamic and Metabolic Effects of Aortic Unclamping Following Emergency Surgery for Traumatic Thoracic Aortic Tear in Shunted and Unshunted Patients. The Journal of Trauma: Injury, Infection, and Critical Care. 31(7). 1007–1016. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026